Delivery Order SPE2DB22D2006-SPE2DB24FV8TP

Award Date 3/13/24
Potential Completion Date 3/14/24
Potential Value $4.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,566,825,377 units of ORENCIA CLICKJECT 125 MG/ML. The $13,096.01 contract has a completion date of January 3, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of ORENCIA CLICKJECT 125 MG/ML pharmaceutical products. The contract has a potential value of $7,718.04 and a completion date of February 8, 2024. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31,...
The U.S. Defense Logistics Agency (DLA) awarded a $7,349.07 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of ORENCIA CLICKJECT 125 MG/MLML pharmaceutical products. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a comprehensive range of medical commodities to support military...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ORENCIA CLICKJECT 125 MG/ML pharmaceutical products. The $6,663.84 contract has a period of performance through February 8, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this delivery order and also holds an indefinite delivery contract (IDC) with DLA with a...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $10,394.69, is for the supply of ORENCIA CLICKJECT 125 MG/MLML, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp with a...
This is a $19,060.44 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides ORENCIA CLICKJECT 125 MG/MLML medical supplies, with a period of performance through June 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which enables the company to supply a...
This is a $51,458.90 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of ORENCIA CLICKJECT 125 MG/MLML pharmaceutical product, with a period of performance through August 23, 2024. This order is placed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
The U.S. Department of Defense's Medical Supply Chain (VPDLATSMED-A) awarded a $10,432.32 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4564602177 - ORENCIA CLICKJECT 125 MG/MLML, a pharmaceutical product, with a performance completion date of May 15, 2024. This delivery order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ORENCIA CLICKJECT 125 MG/ML, a specialty pharmaceutical product. The contract has a potential value of $23,399.63 and a completion date of March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation. This delivery order is issued under a larger indefinite delivery contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $52,810.88, is a delivery order for 4,567,405,227 units of ORENCIA CLICKJECT 125 MG/ML medication. The contract has a firm fixed price and an ultimate completion date of February 28, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FV8TP
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4563954822 ORENCIA CLICKJECT 125 MG/MLML. The contract has a ceiling value of $4,670.52 and a period of performance through March 14, 2024. This award is a task order under a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.

Generated 6/12/24, 10:12 AM